DHFR-ASC

Known as: dihydrofolate reductase-ASC 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2018
012319912018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Hypertrophic scar (HS) is a dermal fibroproliferative disease characterized by fibroblast over-proliferation, overproduction, and… (More)
Is this relevant?
2017
2017
Malat1 contributes to enzalutamide resistance in castration-resistant prostate cancer (CRPC) by promoting the expression of the… (More)
Is this relevant?
2016
2016
BACKGROUND Ascorbic acid is proposed to have antitumor potential against certain cancer types but has the limitation of requiring… (More)
Is this relevant?
2015
2015
Recent studies suggest that the androgen receptor (AR) might play important roles in influencing bladder cancer progression, yet… (More)
Is this relevant?
2015
2015
There is a clinical need for small-diameter vascular substitutes, notably for coronary and peripheral artery bypass procedures… (More)
Is this relevant?
2015
2015
Omental adipose stromal cells (O-ASC) are a multipotent population of mesenchymal stem cells contained in the omentum tissue that… (More)
  • figure 1
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2012
2012
Adipose-derived stromal/mesenchymal stem cells (ASC) have gained interest as promising tools for delivering cancer therapy… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2012
2012
Metabolic pathologies mainly originate from adipose tissue (AT) dysfunctions. AT differences are associated with fat-depot… (More)
Is this relevant?
2009
2009
BACKGROUND The chondrogenic differentiation potential of the easily accessible adipose tissue-derived stem cells (ASCs) is of… (More)
Is this relevant?
2003
2003
Pancreatic cancer is an aggressive tumor with short median survival and high mortality rate. Alternative therapeutic modalities… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?